<html><head></head><body><h1>Deprizine</h1><p class="drug-subtitle"><b>Generic Name:</b> ranitidine hydrochloride<br/>
<b>Dosage Form:</b> kit for oral suspension<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><h2>Principal Display Panel</h2><p>Do not use if safety seal is broken</p><p><span class="Bold">NDC 43093-102-01</span></p><p><span class="Bold">Rx only</span></p><p><span class="Bold">FusePaq™  Compounding Kit for Oral Suspension</span></p><p><span class="Bold">Deprizine™</span></p><p><span class="Bold">(ranitidine hydrochloride 16.8 mg/mL [15 mg/mL ranitidine], in oral suspension - compounding kit)</span></p><p><br/>
<span class="Bold">Description:</span><br/>
This kit contains active and inactive bulk materials to compound a ranitidine hydrochloride oral suspension. The instructions describe how to prepare 250 mL of a compounded oral suspension containing 16.8 mg/mL ranitidine hydrochloride (15 mg/mL as ranitidine). Other concentrations are possible. Exact strength of compounded suspension must be defined by the prescriber.</p><p><br/>
<span class="Bold">Active Ingredient:</span><br/></p><ul>
<li>4.2 g ranitidine hydrochloride, USP</li>
</ul><p><span class="Bold">Inactive Ingredients:</span></p><ul>
<li>250 mL oral suspension vehicle (water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, sodium citrate, citric acid, potassium sorbate, sodium benzoate)</li>
<li>Press-in bottle adaptor for oral dispenser</li>
<li>Oral dispenser</li>
<li>Instructions<br/></li>
</ul><p><span class="Bold">For Prescription Compounding Only</span></p><p><span class="Bold">U.S. Patents Pending</span></p><p><span class="Bold">CS38-A1 rev 1</span></p><p></p><h2>Drug Label</h2><p class="First">Do not use if safety seal is broken<br/>
For Prescription Compounding Only</p><p><span class="Bold">Ranitidine Hydrochloride</span></p><p>Net contents: 4.2 g<br/>
Repackaged by:<br/>
Fusion Pharmaceuticals, LLC<br/>
Camarillo, CA 93012</p><p>CS35-A1 rev 0</p><p></p><h2>Suspension Label</h2><p class="First">Do not use if safety seal is broken<br/>
For Prescription Compounding Only</p><p><span class="Bold">Oral Suspension Vehicle</span><br/>
Sugar, dye, and paraben free</p><p><span class="Bold">Ingredients:</span> water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, potassium sorbate, sodium benzoate<br/></p><p>Net Contents: 250 mL (8.4 fl oz)</p><p>Manufactured for:<br/>
Fusion Pharmaceuticals LLC<br/>
Camarillo, CA 93012</p><p>CS36-A1 rev 0</p><p></p><h2>Instructions Insert</h2><p class="First"><span class="Bold">NDC 43093-102-01</span></p><p><span class="Bold">Rx only</span></p><p><span class="Bold">FusePaq™</span></p><p><span class="Bold">Deprizine™</span></p><p><span class="Bold">(ranitidine hydrochloride 16.8 mg/mL [15 mg/mL ranitidine], in oral suspension - compounding kit)</span></p><p><br/></p><p><span class="Italics">FusePaq™ compounding kits provide a convenient approach to rapidly compound prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practice (cGMP).</span></p><p><span class="Bold"><br/>
For Prescription Compounding Only</span></p><p><span class="Bold"><br/>
Description:</span><br/>
<br/>
This kit contains active and inactive bulk materials to compound a ranitidine hydrochloride oral suspension. These instructions describe how to prepare 250 mL of a compounded oral suspension containing 16.8 mg/mL ranitidine hydrochloride (15 mg/mL as ranitidine). Other concentrations are possible. Exact strength of compounded suspension must be defined by the prescriber.<br/></p><p><span class="Bold"><br/>
Contents:</span><br/></p><ul>
<li>4.2 g ranitidine hydrochloride, USP</li>
<li>250 mL oral suspension vehicle (water, glycerin, L-glutamine, xylitol, monoammonium glycyrrhizinate, pineapple flavor, xanthan gum, stevia powder, orange flavor, citric acid, sodium citrate, potassium sorbate, sodium benzoate)</li>
<li>Press-in bottle adaptor for oral dispenser</li>
<li>Oral dispenser</li>
<li>Instructions</li>
</ul><p><span class="Bold">Instructions for Compounding</span><br/>
Ranitidine hydrochloride, 16.8 mg/mL (15 mg/mL as ranitidine) oral suspension<br/></p><p><br/>
<span class="Bold">1    Remove and Inspect the Contents of the Kit<br/>
<br/></span> Ensure that the safety seals are present and intact on the ranitidine hydrochloride and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.</p><p><br/>
<span class="Bold">2    Prepare for Mixing<br/>
<br/></span> Wear gloves and eye protection during compounding operations. Remove the seal from the oral suspension bottle. Break the perforated seal and remove the cap from the ranitidine hydrochloride bottle.</p><p><br/>
<span class="Bold">3    Transfer Ranitidine Hydrochloride to the Suspension Bottle<br/>
<br/></span> Uncap the suspension bottle. Pour a small amount of suspension liquid (approximately one-third to one-half the volume of the ranitidine hydrochloride bottle) into the ranitidine hydrochloride bottle. Cap the ranitidine hydrochloride bottle and shake well several times to dissolve the ranitidine hydrochloride powder. Empty the contents into the suspension bottle. Cap and mix the suspension bottle. Repeat this step 3 times. Visually ensure that all of the ranitidine hydrochloride has been dissolved and transferred to the suspension bottle.</p><p><br/>
<span class="Bold">4    Complete the Mixing Process<br/>
<br/></span> Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times.</p><p><br/>
<span class="Bold">5    Re-label the Compounded Suspension<br/>
<br/></span> Label the compounded suspension per the pharmacy's standard practice. Remove or obscure the oral suspension vehicle label, since the label is no longer accurate once compounding is completed.<br/></p><p><br/></p><p><span class="Italics">Store the unused kit at room temperature of 15-30°C (59-86°F). <span class="Bold">Once prepared, store the mixed suspension between 2-8°C (36-46°F)</span> . The compounded suspension is stable for at least eight weeks when stored under refrigeration, based upon real-time and accelerated stability studies.</span></p><p><span class="Italics">Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test &lt;61&gt;. In addition, the suspension vehicle formulation has passed the USP &lt;51&gt; Antimicrobial Effectiveness Test.<br/>
<br/>
An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.</span></p><p><br/>
<span class="Bold">U.S. Patents Pending</span><br/></p><p><br/>
Manufactured by:<br/>
Fusion Pharmaceuticals LLC<br/>
768 Calle Plano<br/>
Camarillo, CA 93012</p><p>CS43-A1 rev 1</p><p></p><p></p><h2>More about Deprizine (ranitidine)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: H2 antagonists</li>
<li>FDA Alerts (18)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Ranitidine Tablets &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Duodenal Ulcer</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li>Erosive Esophagitis</li>
<li>Gastric Ulcer Maintenance Treatment</li>
<li data-more-config-id="list-data-resources-conditions">... +8 more</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>